Platelets

Evolution Calcium Children Diabetes mellitus Fetus Gene expression. Gene therapy Genetics Inflammation Insulin resistance. Lymphocytes Mass spectrometry Aspirin Glycosylation N†o Ligands Atrial fibrillation Myocardial infarction Down syndrome Blood platelets Infection Congenital heart disease Complement Computational biology Endothelium Membrane proteins Animal models Bioreactors Megakaryocytes Hemostasis Coagulation Atherosclerosis Lipids Endocytosis Oxidative stress Collagen Embryonic stem cells Lung Neutrophils Chemokines Integrins Flow cytometry Lysosomes Nitric oxide Antiphospholipid syndrome Guideline Heparin Antibodies Actin Cardiopulmonary bypass Cargo Cytoskeleton Endothelial Cells Exocytosis Fibrinogen Hyperglycemia Leukocytes Microtubules Monocytes Coronary Artery Disease Fibrinolysis Membrane fusion Aggregation Paraproteinemia Hemolytic-uremic syndrome Acute Coronary Syndrome Microfluidic devices Cerebral Hemorrhage Clopidogrel Induced Pluripotent Stem Cells Clinical trial MicroRNA Fibrin Exosomes Laboratory diagnosis Bernard-Soulier Syndrome Intravital microscopy Mechanisms of Action Hemarthrosis Adenosine diphosphate (ADP) Function Immune Antiplatelet therapy Glanzmann Thrombasthenia Neonate MRNA Myeloproliferative neoplasms Hydroxyurea Factor XIII Essential thrombocythemia Kinase Mammal Liver disease Biomarkers Lymphangiogenesis ITP Angiogenesis Extracellular vesicles Microparticles G protein-coupled receptors Invertebrate Kawasaki disease Megakaryocyte Adverse events Endothelial Dysfunction Heterogeneity Granules NETs Immune Thrombocytopenia Cell reprogramming GTPase Blood clotting Mechanoreceptor DIGE Cardiovascular Disease Cyclooxygenase Adenosine triphosphate (ATP) Clinical approach Bleeding MiRNA Gray Platelet Syndrome Anticoagulant Gastrointestinal Bleeding Microvesicles Gene regulation Membrane trafficking Acute Chest Syndrome Colorectal cancer Cross-linking Mass cytometry Inherited Abciximab ADAMTS13 Acquired von Willebrand syndrome Aggregometry Alloimmune thrombocytopenia Acquired platelet disorders Antiplatelet agents antiplatelet antibodies Atypical hemolytic-uremic syndrome Avatrombopag Beta1-tubulin amebocyte Cell count/instrumentation Cell count/methods Blood Smear cilostazol Antiplatelet drugs CLEC-2 Argatroban Comparative hemostasis Bivalirudin Dipyridamole Cangrelor Cardioembolism Danaparoid Dense tubular system Dense granules CD39 disseminated intravascular coagulation Coronary stents Evolution of platelets Fetal thrombocytopenia Diacylglycerol Direct differentiation Fondaparinux Drug-induced thrombocytopenia Congenital amegakaryocytic thrombocytopenia Eptifibatide GPVI Factor V FVIIa analogs Glycoprotein IIb-IIIa Hematopoietic stem cell (HSC) Hemocyte Inherited platelet bleeding disorders Hirudin Integrin activation drug sensitivity HemITAM Eltrombopag Macrothrombocytopenia Jacobsen syndrome Facilitated percutaneous coronary intervention Factor VIIa (FVIIa) Microangiopathic hemolytic anemia Filamin A Mechano-sensitive Flow cytometry/methods Multiplate messenger RNA (mRNA) Neonatal platelet transfusion GPIb G6b-B GATA-1 mutation mRNA translation P2X1 P2Y1 Pathogen reduction GPIIb-IIIa HIPA test Neonatal alloimmune thrombocytopenia PAR1 P2Y12 antagonists Immunoreceptor tyrosine-based inhibition motif PECAM-1 Intrinsic tenase Leukocyte-platelet aggregates ITAM receptors Inherited platelet disorders Kindlin IVIG Lumiaggregometry MYH9-RT Mean platelet volume Open-canalicular system P2Y12 PAI-1 Palmitoylation Patent Foramen Ovale limulus Neonatal thrombocytopenia Massive transfusion Megakaryocyte-specific transgene expression PAR3 Paris-Trousseau syndrome